(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - Genflow Biosciences PLC on Thursday said loss narrowed in the first half of 2023, as it managed to slash administrative expenses. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - Genflow Biosciences PLC on Tuesday said it began trading on the OTCQB Venture Market in the US, in addition to its London Stock Exchange Main Market listing. Read More
Genflow Biosciences - London-based biotechnology company focused on longevity, with research & development facilities in Belgium - Names Tamara Joseph, a US-based non-executive director, as new chair. Points out Joseph has an impressive track record in public and private financings, having supported Nasdaq financings in excess of USD800 million. Read More
(Alliance News) - Genflow Biosciences PLC shares jumped on Wednesday, after it said it has submitted an application for trading of its shares on the OTCQB Venture Market in the US. Read More
(Alliance News) - Genflow Biosciences PLC on Tuesday praised a "resurgence of interest in the longevity sector", positively noting a secure financial position. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
Genflow Biosciences PLC - London-based biotechnology company - Enters into a research agreement with Magnitude Biosciences Ltd, a UK-based biotechnology research organisation focused on drug discovery and product development. The collaboration will accelerate Genflow's therapeutic developments. Company adds that it will put it "on track" to carry out its research and pre-clinical drug discovery. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
Genflow Biosciences PLC - London-based biotechnology company - Enters into a collaborative research agreement with Organips, a French biotechnology company. The collaboration will research the potential of the Sirtuin-6 gene variant found in people aged 100 and over in reserving the ageing process in cells from patients with Werner syndrome. Werner syndrome is a rare condition characterised by premature ageing. Read More
(Alliance News) Genflow Biosciences PLC - London-based biotechnology firm focused on longevity and development of therapies to counteract the effects of ageing - Begins scientific research collaboration with the University of Rochester's Aging Research Center. Says collaboration will initially research the potential of Sirtuin-6 in reversing the aging process in liver tissue. This is the first step towards a true rejuvenation gene therapy across a range of tissues, it adds. Read More